Alzheimer's Disease | World Briefings
Subscribe to World Briefings's newsletter

News Updates

Let's join our newsletter!

Do not worry we don't spam!

ProMIS Neurosciences to Showcase PMN310 at International Conference on Cognitive & Behavioral Neurosciences

World

12 Sep, 2024

ProMIS Neurosciences to Showcase PMN310 at International Conference on Cognitive & Behavioral Neurosciences


ProMIS Neurosciences Inc. (Nasdaq: PMN), a biotechnology company specializing in antibody therapeutics for neurodegenerative diseases like Alzheimer's disease (AD), amyotrophic...

Newsletter
Subscribe to Newsletter

Stay Tuned With Updates